★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN   Learn more →

Log In  |  Become a Member  |  Sponsor  |  ⌕ Search

Established in 1999

News/Compliance & Enforcement/Biomedical Company Avoids DOJ Prosecution After First Ever Voluntary Corporate Self-Disclosure of Fraud
Expert Opinion·Compliance & Enforcement Brief

Biomedical Company Avoids DOJ Prosecution After First Ever Voluntary Corporate Self-Disclosure of Fraud

JL
Joshua LimMay 31, 2024 · 1 min read
🔒 Members Only

ArentFox Schiff – On May 22, the US Department of Justice (DOJ) announced that it will not prosecute a Massachusetts biomedical company, DBA MilliporeSigma, for fraudulent conduct and conspiracy.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year
Become a Member
Sign In
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.